Bailard’s Immunovant IMVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-6,300
Closed -$265K 774
2023
Q4
$265K Hold
6,300
0.01% 575
2023
Q3
$242K Buy
+6,300
New +$242K 0.01% 600
2023
Q2
Sell
-12,200
Closed -$189K 735
2023
Q1
$189K Hold
12,200
0.01% 661
2022
Q4
$217K Buy
+12,200
New +$217K 0.01% 631